What is the share price of Ortin Global Ltd (ORTINGLOBE) today?
The share price of ORTINGLOBE as on 21st September 2026 is ₹15.36. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ortin Global Ltd (ORTINGLOBE) share?
The past returns of Ortin Global Ltd (ORTINGLOBE) share are- Past 1 week: -12.23%
- Past 1 month: -0.32%
- Past 3 months: -8.08%
- Past 6 months: 3.78%
- Past 1 year: 28.00%
- Past 3 years: -22.81%
- Past 5 years: -41.37%
What are the peers or stocks similar to Ortin Global Ltd (ORTINGLOBE)?
The peers or stocks similar to Ortin Global Ltd (ORTINGLOBE) include:What is the market cap of Ortin Global Ltd (ORTINGLOBE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ortin Global Ltd (ORTINGLOBE) is ₹12.49 Cr as of 21st September 2026.What is the 52 week high and low of Ortin Global Ltd (ORTINGLOBE) share?
The 52-week high of Ortin Global Ltd (ORTINGLOBE) is ₹21.30 and the 52-week low is ₹10.66.What is the PE and PB ratio of Ortin Global Ltd (ORTINGLOBE) stock?
The P/E (price-to-earnings) ratio of Ortin Global Ltd (ORTINGLOBE) is -16.65. The P/B (price-to-book) ratio is 10.07.Which sector does Ortin Global Ltd (ORTINGLOBE) belong to?
Ortin Global Ltd (ORTINGLOBE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ortin Global Ltd (ORTINGLOBE) shares?
You can directly buy Ortin Global Ltd (ORTINGLOBE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ortin Global Ltd
ORTINGLOBE Share Price
NSE₹15.362.97% (-0.47)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ORTINGLOBE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ORTINGLOBE Performance & Key Metrics
ORTINGLOBE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -13.88 | 10.07 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.66 | 5.98 | 0.47% |
ORTINGLOBE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ORTINGLOBE Company Profile
Ortin Laboratories Limited is engaged in the business of manufacturing and trading of pharmaceuticals, drugs and intermediates.
SUNPHARMA
PE Ratio
39.06
39.06
1Y Return
13.68%
13.68%
Buy Reco %
93.33
93.33
TORNTPHARM
PE Ratio
87.38
87.38
1Y Return
35.94%
35.94%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.98
22.98
1Y Return
12.10%
12.10%
Buy Reco %
55.56
55.56
CIPLA
PE Ratio
28.87
28.87
1Y Return
10.12%
10.12%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
122.65
122.65
1Y Return
123.22%
123.22%
Buy Reco %
58.33
58.33
ORTINGLOBE Forecast
ORTINGLOBE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ORTINGLOBE
ORTINGLOBE
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ORTINGLOBE Income Statement
ORTINGLOBE Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.31 | 0.21 | 0.05 | 0.05 | 0.09 | 0.08 | 0.01 | 0.01 | 0.31 | 0.02 | ||||||||||
Operating & Other expenses | 3.36 | 0.31 | 0.50 | 0.17 | 0.25 | 0.24 | 0.52 | 0.06 | 0.32 | 0.35 | ||||||||||
EBITDA | -3.05 | -0.10 | -0.45 | -0.12 | -0.16 | -0.16 | -0.51 | -0.05 | -0.01 | -0.33 | ||||||||||
| Depreciation/Amortization | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | -3.10 | -0.10 | -0.45 | -0.12 | -0.16 | -0.16 | -0.51 | -0.05 | -0.01 | -0.33 | ||||||||||
| Interest & Other Items | 0.08 | 0.00 | 0.02 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -3.18 | -0.10 | -0.47 | -0.11 | -0.16 | -0.16 | -0.51 | -0.05 | -0.01 | -0.33 | ||||||||||
| Taxes & Other Items | 0.96 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | -4.14 | -0.10 | -0.47 | -0.12 | -0.16 | -0.17 | -0.51 | -0.05 | -0.01 | -0.33 | ||||||||||
| EPS | -5.10 | -0.13 | -0.58 | -0.13 | -0.20 | -0.22 | -0.62 | -0.07 | -0.01 | -0.42 |
ORTINGLOBE Company Updates
ORTINGLOBE Stock Peers
ORTINGLOBE Past Performance & Peer Comparison
ORTINGLOBE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ortin Global Ltd | -16.65 | 10.07 | — |
| Sun Pharmaceutical Industries Ltd | 39.06 | 5.35 | 0.86% |
| Torrent Pharmaceuticals Ltd | 87.38 | 10.75 | 0.68% |
| Zydus Lifesciences Ltd | 22.98 | 3.91 | 0.09% |
ORTINGLOBE Stock Price Comparison
Compare ORTINGLOBE with any stock or ETFCompare ORTINGLOBE with any stock or ETF
ORTINGLOBE
ORTINGLOBE Holdings
ORTINGLOBE Shareholdings
ORTINGLOBE Promoter Holdings Trend
ORTINGLOBE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ORTINGLOBE Institutional Holdings Trend
ORTINGLOBE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ORTINGLOBE Shareholding Pattern
ORTINGLOBE Shareholding Pattern
ORTINGLOBE Shareholding History
ORTINGLOBE Shareholding History
Foreign Institutions
smallcases containing ORTINGLOBE stock
smallcases containing ORTINGLOBE stock
Looks like this stock is not in any smallcase yet.
ORTINGLOBE Events
ORTINGLOBE Events
ORTINGLOBE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ORTINGLOBE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ORTINGLOBE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ORTINGLOBE has not given any dividends in last 5 years
ORTINGLOBE Upcoming Dividends
ORTINGLOBE Upcoming Dividends
No upcoming dividends are available
ORTINGLOBE Past Dividends
ORTINGLOBE Past Dividends
Cash Dividend
Ex DateEx DateSep 24, 2013
Final
Final | Div/Share: ₹0.25
Dividend/Share
₹0.25
Ex DateEx Date
Sep 24, 2013
Cash Dividend
Ex DateEx DateSep 24, 2012
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Sep 24, 2012
Cash Dividend
Ex DateEx DateOct 13, 2011
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Oct 13, 2011
Cash Dividend
Ex DateEx DateSep 23, 2010
Final
Final | Div/Share: ₹0.80
Dividend/Share
₹0.80
Ex DateEx Date
Sep 23, 2010
ORTINGLOBE Stock News & Opinions
ORTINGLOBE Stock News & Opinions
Articles & Videos
Corporate
Corporate
Ortin Global Limited appoints Prakash Sawant as Managing Director for a three-year termOrtin Global Limited, formerly Ortin Laboratories Limited, announced changes to its board of directors following a meeting on September 7, 2026. Murali Krishna Murthy Sanka will transition from Managing Director to Non-Executive Director, while Prakash Prashant Sawant will assume the role of Managing Director for a three-year term, both effective September 7, 2026. Prakruti Prashant Sawant resigned as Whole-time Director due to professional commitments, and Parveen Satija was appointed as an Additional Director and Whole-time Director for two years, also effective September 7, 2026. The company’s 39th Annual General Meeting is scheduled for September 30, 2026, to be held via video conference or other audio-visual means.
2 weeks agoCapital Market - Live
Corporate
Corporate
Ortin Global Limited appoints Prakash Sawant as Managing Director for a three-year termOrtin Global Limited, formerly Ortin Laboratories Limited, announced changes to its board of directors following a meeting on September 7, 2026. Murali Krishna Murthy Sanka will transition from Managing Director to Non-Executive Director, while Prakash Prashant Sawant will assume the role of Managing Director for a three-year term, both effective September 7, 2026. Prakruti Prashant Sawant resigned as Whole-time Director due to professional commitments, and Parveen Satija was appointed as an Additional Director and Whole-time Director for two years, also effective September 7, 2026. The company’s 39th Annual General Meeting is scheduled for September 30, 2026.
2 weeks agoCapital Market - Live
Corporate
Corporate
Ortin Global will review quarterly financials at a board meeting on August 14, 2026ORTIN GLOBAL LIMITED, formerly known as ORTIN LABORATORIES LIMITED, will hold a board meeting on August 14, 2026, to consider the unaudited financial results for the quarter ended June 30, 2026, along with a limited review report, and any other business with the permission of the chair; the trading window for securities has been closed since July 1, 2026, and will remain so until 48 hours after the financial results are declared.
1 month agoCapital Market - Live
Earnings
Earnings
Ortin Global reports standalone net loss of Rs 0.01 crore in the March 2026 quarterNet Loss of Ortin Global reported to Rs 0.01 crore in the quarter ended March 2026 as against net loss of Rs 0.16 crore during the previous quarter ended March 2025. Sales declined 40.00% to Rs 0.03 crore in the quarter ended March 2026 as against Rs 0.05 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 0.74 crore in the year ended March 2026 as against net loss of Rs 0.85 crore during the previous year ended March 2025. Sales declined 70.59% to Rs 0.10 crore in the year ended March 2026 as against Rs 0.34 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales0.030.05 -40 0.100.34 -71 OPM %-33.33-320.00 --720.00-250.00 - PBDT-0.01-0.16 94 -0.72-0.85 15 PBT-0.01-0.16 94 -0.72-0.86 16 NP-0.01-0.16 94 -0.74-0.85 13 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Ortin Global to table resultsOrtin Global will hold a meeting of the Board of Directors of the Company on 30 May 2026.
3 months agoCapital Market - Live
Earnings
Earnings
Ortin Global reports standalone net loss of Rs 0.05 crore in the December 2025 quarterNet Loss of Ortin Global reported to Rs 0.05 crore in the quarter ended December 2025 as against net loss of Rs 0.11 crore during the previous quarter ended December 2024. Sales declined 66.67% to Rs 0.01 crore in the quarter ended December 2025 as against Rs 0.03 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.010.03 -67 OPM %-500.00-433.33 - PBDT-0.05-0.12 58 PBT-0.05-0.12 58 NP-0.05-0.11 55 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Ortin Global to conduct board meetingOrtin Global will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Earnings
Ortin Global reports standalone net loss of Rs 0.50 crore in the September 2025 quarterNet Loss of Ortin Global reported to Rs 0.50 crore in the quarter ended September 2025 as against net loss of Rs 0.47 crore during the previous quarter ended September 2024. Sales declined 80.00% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.05 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.010.05 -80 OPM %-5000.00-900.00 - PBDT-0.50-0.47 -6 PBT-0.50-0.47 -6 NP-0.50-0.47 -6 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Ortin Global to table resultsOrtin Global will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Ortin Global to hold AGMOrtin Global announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -45.1%, vs industry avg of 11.76%
Over the last 5 years, market share stayed at 0%